Worldwide drive to beat rising number of TB cases
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists, governments and charitable groups around the world have linked up to tackle one of the deadliest infectious diseases - tuberculosis - which is making a comeback after decades in decline.
Scientists, governments and charitable groups around the world have linked up to tackle one of the deadliest infectious diseases - tuberculosis - which is making a comeback after decades in decline.
A global alliance of private firms and public organisations will launch a research programme today to develop a new TB drug by 2010, with a budget of $150m (£100m) in its first five years. No pharmaceutical company would attempt this because the costs could never be recouped from sales.
TB kills more than two million people a year around the world, more than Aids or malaria. Most cases are in poorer countries that cannot afforddrugs, but new drug-resistant strains of the disease are on the rise in the West. Aids sufferers are vulnerable owing to their weak immune systems.
No new TB drug has been developed for 30 years. The side-effects and length of treatments - six to nine months - mean patients often stop before they are clear, allowing drug resistance to develop.
In Britain there are 6,500 TB cases a year, and one in 20 shows signs of drug resistance. In London a new case of multi-drug resistant TB is found each week; cases cost £50,000 to £100,000 each to treat.
The World Health Organisation, which is backing the alliance launched in Bangkok today, declared TB a global emergency in 1993. Dr Gro Harlem Brundtland, the director general, said: "Tuberculosis is not only a cause of misery and death, it is a major impediment to social and economic development."
The target of the alliance is to have TB drugs available by 2010 that will shorten treatment to three months, tackle latent and multi-drug resistant TB and be affordable to all.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments